Literature DB >> 11988193

Effects of resynchronization therapy on sympathetic activity in patients with depressed ejection fraction and intraventricular conduction delay due to ischemic or idiopathic dilated cardiomyopathy.

Mohamed H Hamdan1, Saverio Barbera, Robert C Kowal, Richard L Page, Karthik Ramaswamy, Jose A Joglar, Valeh Karimkhani, Michael L Smith.   

Abstract

This study assesses the effect of biventricular pacing on sympathetic nerve activity (SNA) in patients with depressed ejection fraction and intraventricular conduction delay (IVCD). Biventricular pacing has been shown to result in hemodynamic improvement in patients with depressed ejection fraction and IVCD. The effect of biventricular pacing on SNA, however, remains unclear. A total of 15 men with a mean ejection fraction of 25 +/- 4% were enrolled. Arterial pressure, central venous pressure and SNA were recorded during 3 minutes of right atrial (RA) pacing and RA-biventricular pacing. Pacing was performed at a rate 5 to 10 beats faster than sinus rhythm, with an atrioventricular interval equal to 100 ms during RA-biventricular pacing. RA-biventricular pacing resulted in greater arterial pressures (p <0.05) than RA pacing (146 +/- 15/83 +/- 11 vs 141 +/- 15/80 +/- 10 mm Hg). There were no differences in central venous pressures between the 2 pacing modes (p = 0.76). SNA was significantly less during RA-biventricular pacing (727 +/- 242 U) than during RA pacing (833 +/- 332 U) (p <0.02). Furthermore, there was a positive correlation between baseline QRS duration and the decrease in SNA noted with RA-biventricular pacing (r = 0.58, p = 0.03). Biventricular pacing results in improved hemodynamics and a decrease in SNA compared with intrinsic conduction in patients with left ventricular dysfunction and IVCD. If the current findings are also present with chronic biventricular pacing, then this form of therapy may have a positive impact on mortality.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  2002        PMID: 11988193     DOI: 10.1016/s0002-9149(02)02273-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  15 in total

Review 1.  Role of resynchronisation therapy and implantable cardioverter defibrillators in heart failure.

Authors:  S Ellery; L Williams; M Frenneaux
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

2.  Cardiac Resynchronization Therapy in CKD Stage 4 Patients.

Authors:  Ulas Höke; Mand J H Khidir; Enno T van der Velde; Martin J Schalij; Jeroen J Bax; Victoria Delgado; Nina Ajmone Marsan
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-25       Impact factor: 8.237

3.  Comparison of the haemodynamics of different pacing sites in patients undergoing resynchronisation treatment: need for individualisation of lead localisation.

Authors:  C M C van Campen; F C Visser; C C de Cock; H S Vos; O Kamp; C A Visser
Journal:  Heart       Date:  2006-06-27       Impact factor: 5.994

Review 4.  The role of the autonomic nervous system in sudden cardiac death.

Authors:  Marmar Vaseghi; Kalyanam Shivkumar
Journal:  Prog Cardiovasc Dis       Date:  2008 May-Jun       Impact factor: 8.194

Review 5.  Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients.

Authors:  Mohammed Shurrab; Dennis T Ko; Yazan Zayed; Sankar D Navaneethan; Nour Yadak; Abeer Yaseen; Anna Kaoutskaia; Waad Qamhia; Zakaria Hamdan; Saleem Haj-Yahia; Douglas S Lee; David Newman; Jeff S Healey; Paula Harvey; Eugene Crystal
Journal:  J Interv Card Electrophysiol       Date:  2018-07-30       Impact factor: 1.900

6.  Long term biventricular resynchronisation therapy in advanced heart failure: effect on neurohormones.

Authors:  M U Braun; T Rauwolf; T Zerm; M Schulze; A Schnabel; R H Strasser
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

7.  Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy.

Authors:  Khalid Chakir; Samantapudi K Daya; Takeshi Aiba; Richard S Tunin; Veronica L Dimaano; Theodore P Abraham; Kathryn M Jaques-Robinson; Kathryn Jacques; Edwin W Lai; Karel Pacak; Wei-Zhong Zhu; Rui-ping Xiao; Gordon F Tomaselli; David A Kass
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

8.  Cardiac Resynchronization Therapy for Advanced Heart Failure.

Authors:  Philip B. Adamson; William T. Abraham
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-08

9.  Potential autonomic nervous system effects of statins in heart failure.

Authors:  Tamara B Horwich; Holly R Middlekauff
Journal:  Heart Fail Clin       Date:  2008-04       Impact factor: 3.179

10.  Cardiac resynchronization therapy in the cardiorenal syndrome.

Authors:  Margot K Davis; Sean A Virani
Journal:  Int J Nephrol       Date:  2011-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.